Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/1416 : 17PR Newswire (US)Introducing ZW3D 2025: Embark on a Seamless Journey from Design to Manufacturing
2024/06/1416 : 17PR Newswire (US)Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
2024/06/1416 : 15GlobeNewswire Inc.HSBC Bank plc: Post Stabilisation Notice
2024/06/1416 : 15PR Newswire (Canada)Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
2024/06/1416 : 15PR Newswire (US)Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
2024/06/1416 : 11GlobeNewswire Inc.Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging Market Interest
2024/06/1416 : 06GlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group anuncia transición de director ejecutivo para el día 1ro. de julio de 2024
2024/06/1416 : 06GlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group Anuncia Transição de CEO para o dia 1º de julho de 2024
2024/06/1416 : 06GlobeNewswire Inc.Le groupe Nikkiso Clean Energy & Industrial Gases annonce un changement de direction au 1er juillet 2024
2024/06/1416 : 06GlobeNewswire Inc.Nikkiso Clean Energy & Industrial Gases Group kündigt Wechsel des CEO zum 1. Juli 2024 an
2024/06/1416 : 05GlobeNewswire Inc.Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings ReportNEO:ZEFIZefiro Methane Corp
2024/06/1416 : 05GlobeNewswire Inc.Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings ReportY6B
2024/06/1416 : 05PR Newswire (US)Rigel Announces Five Presentations at the EHA2024 Hybrid CongressNASDAQ:RIGLRigel Pharmaceuticals Inc
2024/06/1416 : 04The Daily HodlHere’s What Needs To Happen for Bitcoin To Hit New All-Time Highs, According to Fidelity Analyst Jurrien TimmerCOIN:BTCUSDBitcoin
2024/06/1416 : 04The Daily HodlHere’s What Needs To Happen for Bitcoin To Hit New All-Time Highs, According to Fidelity Analyst Jurrien TimmerCOIN:FETUSDFetch
2024/06/1416 : 03Business WireVertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) CongressNASDAQ:VRTXVertex Pharmaceuticals Inc
2024/06/1416 : 02GlobeNewswire Inc.Flash News: OKX Announces Exclusive Minting of Slerf NFTs on its Marketplace
2024/06/1416 : 01PR Newswire (US)The Safavi Impact Institute Sponsors NASA's Space Center Houston's pilot education program in Austria
2024/06/1416 : 01PR Newswire (US)MSC Cruises launches first Tea Library at sea to create perfect cuppa from home for Brits
2024/06/1416 : 01GlobeNewswire Inc.Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
2024/06/1416 : 00Business WireELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaNYSE:PFEPfizer Inc
2024/06/1416 : 00GlobeNewswire Inc.Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell DiseaseNASDAQ:BEAMBeam Therapeutics Inc
2024/06/1416 : 00GlobeNewswire Inc.Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
2024/06/1416 : 00Business WireImmune-Onc Therapeutics to Present Additional Positive Interim Data from IO-202 Phase 1b Expansion Cohort in Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Association (EHA) Annual Congress
2024/06/1416 : 00Business WireNew Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of TreatmentNASDAQ:GILDGilead Sciences Inc
2024/06/1416 : 00GlobeNewswire Inc.Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
2024/06/1416 : 00PR Newswire (US)Brickken is selected to participate in the European Blockchain Regulatory Sandbox
2024/06/1416 : 00PR Newswire (US)Top tips for retail store remodeling from the Paso Robles general contractor
2024/06/1416 : 00PR Newswire (US)Protecting the vulnerable--Atascadero estate planning attorney on guardianships and conservatorships
2024/06/1416 : 00PR Newswire (US)Brickken is selected to participate in the European Blockchain Regulatory Sandbox